Global Preventer Asthma Inhaler Market Research Report 2024

Publication ID:

PB507243175

Publication Date:

July 15, 2024

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Preventer Asthma Inhaler market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Preventer Asthma Inhaler is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preventer Asthma Inhaler is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Preventer Asthma Inhaler include GSKpro, 3M, Aristopharma, Intas Pharmaceuticals, Sensirion, Adherium, AstraZeneca, Boehringer Ingelheim and Glenmark, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preventer Asthma Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventer Asthma Inhaler.
Report Scope
The Preventer Asthma Inhaler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preventer Asthma Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventer Asthma Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSKpro
3M
Aristopharma
Intas Pharmaceuticals
Sensirion
Adherium
AstraZeneca
Boehringer Ingelheim
Glenmark
Vectura
Chiesi
Cipla
Hovione
Mylan
Merck
Segment by Type
Metered-dose (MDIs)
Breath-actuated Inhalers (BAIs)
Dry Powder Inhalers (DPIs)
Segment by Application
Personal
Hospital
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventer Asthma Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventer Asthma Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Preventer Asthma Inhaler Market Overview
1.1 Product Overview and Scope of Preventer Asthma Inhaler
1.2 Preventer Asthma Inhaler Segment by Type
1.2.1 Global Preventer Asthma Inhaler Market Value Comparison by Type (2024-2030)
1.2.2 Metered-dose (MDIs)
1.2.3 Breath-actuated Inhalers (BAIs)
1.2.4 Dry Powder Inhalers (DPIs)
1.3 Preventer Asthma Inhaler Segment by Application
1.3.1 Global Preventer Asthma Inhaler Market Value by Application: (2024-2030)
1.3.2 Personal
1.3.3 Hospital
1.3.4 Clinics
1.4 Global Preventer Asthma Inhaler Market Size Estimates and Forecasts
1.4.1 Global Preventer Asthma Inhaler Revenue 2019-2030
1.4.2 Global Preventer Asthma Inhaler Sales 2019-2030
1.4.3 Global Preventer Asthma Inhaler Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Preventer Asthma Inhaler Market Competition by Manufacturers
2.1 Global Preventer Asthma Inhaler Sales Market Share by Manufacturers (2019-2024)
2.2 Global Preventer Asthma Inhaler Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Preventer Asthma Inhaler Average Price by Manufacturers (2019-2024)
2.4 Global Preventer Asthma Inhaler Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Preventer Asthma Inhaler, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Preventer Asthma Inhaler, Product Type & Application
2.7 Preventer Asthma Inhaler Market Competitive Situation and Trends
2.7.1 Preventer Asthma Inhaler Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Preventer Asthma Inhaler Players Market Share by Revenue
2.7.3 Global Preventer Asthma Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Preventer Asthma Inhaler Retrospective Market Scenario by Region
3.1 Global Preventer Asthma Inhaler Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Preventer Asthma Inhaler Global Preventer Asthma Inhaler Sales by Region: 2019-2030
3.2.1 Global Preventer Asthma Inhaler Sales by Region: 2019-2024
3.2.2 Global Preventer Asthma Inhaler Sales by Region: 2025-2030
3.3 Global Preventer Asthma Inhaler Global Preventer Asthma Inhaler Revenue by Region: 2019-2030
3.3.1 Global Preventer Asthma Inhaler Revenue by Region: 2019-2024
3.3.2 Global Preventer Asthma Inhaler Revenue by Region: 2025-2030
3.4 North America Preventer Asthma Inhaler Market Facts & Figures by Country
3.4.1 North America Preventer Asthma Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Preventer Asthma Inhaler Sales by Country (2019-2030)
3.4.3 North America Preventer Asthma Inhaler Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Preventer Asthma Inhaler Market Facts & Figures by Country
3.5.1 Europe Preventer Asthma Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Preventer Asthma Inhaler Sales by Country (2019-2030)
3.5.3 Europe Preventer Asthma Inhaler Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Preventer Asthma Inhaler Market Facts & Figures by Country
3.6.1 Asia Pacific Preventer Asthma Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Preventer Asthma Inhaler Sales by Country (2019-2030)
3.6.3 Asia Pacific Preventer Asthma Inhaler Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Preventer Asthma Inhaler Market Facts & Figures by Country
3.7.1 Latin America Preventer Asthma Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Preventer Asthma Inhaler Sales by Country (2019-2030)
3.7.3 Latin America Preventer Asthma Inhaler Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Preventer Asthma Inhaler Market Facts & Figures by Country
3.8.1 Middle East and Africa Preventer Asthma Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Preventer Asthma Inhaler Sales by Country (2019-2030)
3.8.3 Middle East and Africa Preventer Asthma Inhaler Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Preventer Asthma Inhaler Sales by Type (2019-2030)
4.1.1 Global Preventer Asthma Inhaler Sales by Type (2019-2024)
4.1.2 Global Preventer Asthma Inhaler Sales by Type (2025-2030)
4.1.3 Global Preventer Asthma Inhaler Sales Market Share by Type (2019-2030)
4.2 Global Preventer Asthma Inhaler Revenue by Type (2019-2030)
4.2.1 Global Preventer Asthma Inhaler Revenue by Type (2019-2024)
4.2.2 Global Preventer Asthma Inhaler Revenue by Type (2025-2030)
4.2.3 Global Preventer Asthma Inhaler Revenue Market Share by Type (2019-2030)
4.3 Global Preventer Asthma Inhaler Price by Type (2019-2030)
5 Segment by Application
5.1 Global Preventer Asthma Inhaler Sales by Application (2019-2030)
5.1.1 Global Preventer Asthma Inhaler Sales by Application (2019-2024)
5.1.2 Global Preventer Asthma Inhaler Sales by Application (2025-2030)
5.1.3 Global Preventer Asthma Inhaler Sales Market Share by Application (2019-2030)
5.2 Global Preventer Asthma Inhaler Revenue by Application (2019-2030)
5.2.1 Global Preventer Asthma Inhaler Revenue by Application (2019-2024)
5.2.2 Global Preventer Asthma Inhaler Revenue by Application (2025-2030)
5.2.3 Global Preventer Asthma Inhaler Revenue Market Share by Application (2019-2030)
5.3 Global Preventer Asthma Inhaler Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSKpro
6.1.1 GSKpro Corporation Information
6.1.2 GSKpro Description and Business Overview
6.1.3 GSKpro Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSKpro Preventer Asthma Inhaler Product Portfolio
6.1.5 GSKpro Recent Developments/Updates
6.2 3M
6.2.1 3M Corporation Information
6.2.2 3M Description and Business Overview
6.2.3 3M Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.2.4 3M Preventer Asthma Inhaler Product Portfolio
6.2.5 3M Recent Developments/Updates
6.3 Aristopharma
6.3.1 Aristopharma Corporation Information
6.3.2 Aristopharma Description and Business Overview
6.3.3 Aristopharma Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aristopharma Preventer Asthma Inhaler Product Portfolio
6.3.5 Aristopharma Recent Developments/Updates
6.4 Intas Pharmaceuticals
6.4.1 Intas Pharmaceuticals Corporation Information
6.4.2 Intas Pharmaceuticals Description and Business Overview
6.4.3 Intas Pharmaceuticals Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Intas Pharmaceuticals Preventer Asthma Inhaler Product Portfolio
6.4.5 Intas Pharmaceuticals Recent Developments/Updates
6.5 Sensirion
6.5.1 Sensirion Corporation Information
6.5.2 Sensirion Description and Business Overview
6.5.3 Sensirion Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sensirion Preventer Asthma Inhaler Product Portfolio
6.5.5 Sensirion Recent Developments/Updates
6.6 Adherium
6.6.1 Adherium Corporation Information
6.6.2 Adherium Description and Business Overview
6.6.3 Adherium Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Adherium Preventer Asthma Inhaler Product Portfolio
6.6.5 Adherium Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Preventer Asthma Inhaler Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Corporation Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boehringer Ingelheim Preventer Asthma Inhaler Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 Glenmark
6.9.1 Glenmark Corporation Information
6.9.2 Glenmark Description and Business Overview
6.9.3 Glenmark Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Glenmark Preventer Asthma Inhaler Product Portfolio
6.9.5 Glenmark Recent Developments/Updates
6.10 Vectura
6.10.1 Vectura Corporation Information
6.10.2 Vectura Description and Business Overview
6.10.3 Vectura Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vectura Preventer Asthma Inhaler Product Portfolio
6.10.5 Vectura Recent Developments/Updates
6.11 Chiesi
6.11.1 Chiesi Corporation Information
6.11.2 Chiesi Preventer Asthma Inhaler Description and Business Overview
6.11.3 Chiesi Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chiesi Preventer Asthma Inhaler Product Portfolio
6.11.5 Chiesi Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Preventer Asthma Inhaler Description and Business Overview
6.12.3 Cipla Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cipla Preventer Asthma Inhaler Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Hovione
6.13.1 Hovione Corporation Information
6.13.2 Hovione Preventer Asthma Inhaler Description and Business Overview
6.13.3 Hovione Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hovione Preventer Asthma Inhaler Product Portfolio
6.13.5 Hovione Recent Developments/Updates
6.14 Mylan
6.14.1 Mylan Corporation Information
6.14.2 Mylan Preventer Asthma Inhaler Description and Business Overview
6.14.3 Mylan Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Mylan Preventer Asthma Inhaler Product Portfolio
6.14.5 Mylan Recent Developments/Updates
6.15 Merck
6.15.1 Merck Corporation Information
6.15.2 Merck Preventer Asthma Inhaler Description and Business Overview
6.15.3 Merck Preventer Asthma Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Merck Preventer Asthma Inhaler Product Portfolio
6.15.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Preventer Asthma Inhaler Industry Chain Analysis
7.2 Preventer Asthma Inhaler Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Preventer Asthma Inhaler Production Mode & Process
7.4 Preventer Asthma Inhaler Sales and Marketing
7.4.1 Preventer Asthma Inhaler Sales Channels
7.4.2 Preventer Asthma Inhaler Distributors
7.5 Preventer Asthma Inhaler Customers
8 Preventer Asthma Inhaler Market Dynamics
8.1 Preventer Asthma Inhaler Industry Trends
8.2 Preventer Asthma Inhaler Market Drivers
8.3 Preventer Asthma Inhaler Market Challenges
8.4 Preventer Asthma Inhaler Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GSKpro
3M
Aristopharma
Intas Pharmaceuticals
Sensirion
Adherium
AstraZeneca
Boehringer Ingelheim
Glenmark
Vectura
Chiesi
Cipla
Hovione
Mylan
Merck

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂